Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1998 Feb 15;26(4):1099–1106. doi: 10.1093/nar/26.4.1099

alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.

K Pongracz 1, S M Gryaznov 1
PMCID: PMC147364  PMID: 9461474

Abstract

The synthesis and hybridization properties of novel nucleic acid analogs, alpha-anomeric oligodeoxyribonucleotide N3'-->P5' phosphoramidates, are described. The alpha-3'-aminonucleoside building blocks used for oligonucleotide synthesis were synthesized from 3'-azido-3'-deoxythymidine or 3'-azido-2',3'-dideoxyuridine via acid catalyzed anomerization or transglycosylation reactions. The base-protected alpha-5'-O-DMT-3'-aminonucleosides were assembled into dimers and oligonucleotides on a solid support using the oxidative phosphorylation method.1H NMR analysis of the alpha-N3'-->P5' phosphoramidate dimer structures indicates significant differences in the sugar puckering of these compounds relative to the beta-N3'-->P5' phosphoramidates and to the alpha-phosphodiester counterparts. Additionally, the ability of the alpha-oligonucleotide N3'-->P5' phosphoramidates to form duplexes was studied using thermal denaturation experiments. Thus the N3'-->P5' phosphoramidate decamer containing only alpha-thymidine residues did not bind to poly(A) and exhibited lower duplex thermal stability with poly(dA) than that for the corresponding beta-anomeric phosphoramidate counterpart. A mixed base decamer alpha-CTTCTTCCTT formed duplexes with the RNA and DNA complementary strands only in a parallel orientation. Melting temperatures of these complexes were significantly lower, by 34-47 or 15-25 degrees C, than for the duplexes formed by the isosequential beta-phosphoramidates in antiparallel and parallel orientations respectively. In contrast, the alpha-decaadenylic N3'-->P5' phosphoramidate formed duplexes with both RNA and DNA complementary strands with a stability similar to that of the corresponding beta-anomeric phosphoramidate. Moreover, the self-complementary oligonucleotide alpha-ATATATATAT did not form an alpha:alpha homoduplex. These results demonstrate the effects of 3'-aminonucleoside anomeric configuration on sugar puckering and consequently on stability of the duplexes.

Full Text

The Full Text of this article is available as a PDF (125.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayever E., Iversen P. L., Bishop M. R., Sharp J. G., Tewary H. K., Arneson M. A., Pirruccello S. J., Ruddon R. W., Kessinger A., Zon G. Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev. 1993 Winter;3(4):383–390. doi: 10.1089/ard.1993.3.383. [DOI] [PubMed] [Google Scholar]
  2. Bielinska A., Shivdasani R. A., Zhang L. Q., Nabel G. J. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990 Nov 16;250(4983):997–1000. doi: 10.1126/science.2237444. [DOI] [PubMed] [Google Scholar]
  3. Bock L. C., Griffin L. C., Latham J. A., Vermaas E. H., Toole J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 1992 Feb 6;355(6360):564–566. doi: 10.1038/355564a0. [DOI] [PubMed] [Google Scholar]
  4. Boiziau C., Debart F., Rayner B., Imbach J. L., Toulme J. J. Chimeric alpha-beta oligonucleotides as antisense inhibitors of reverse transcription. FEBS Lett. 1995 Mar 13;361(1):41–45. doi: 10.1016/0014-5793(95)00138-y. [DOI] [PubMed] [Google Scholar]
  5. Chen J. K., Schultz R. G., Lloyd D. H., Gryaznov S. M. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates. Nucleic Acids Res. 1995 Jul 25;23(14):2661–2668. doi: 10.1093/nar/23.14.2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crooke S. T., Grillone L. R., Tendolkar A., Garrett A., Fratkin M. J., Leeds J., Barr W. H. A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts. Clin Pharmacol Ther. 1994 Dec;56(6 Pt 1):641–646. doi: 10.1038/clpt.1994.189. [DOI] [PubMed] [Google Scholar]
  7. De Mesmaeker A., Altmann K. H., Waldner A., Wendeborn S. Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr Opin Struct Biol. 1995 Jun;5(3):343–355. doi: 10.1016/0959-440x(95)80096-4. [DOI] [PubMed] [Google Scholar]
  8. Debart F., Rayner B., Degols G., Imbach J. L. Synthesis and base-pairing properties of the nuclease-resistant alpha-anomeric dodecaribonucleotide alpha-[r(UCUUAACCCACA)]. Nucleic Acids Res. 1992 Mar 25;20(6):1193–1200. doi: 10.1093/nar/20.6.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ding D., Grayaznov S. M., Lloyd D. H., Chandrasekaran S., Yao S., Ratmeyer L., Pan Y., Wilson W. D. An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res. 1996 Jan 15;24(2):354–360. doi: 10.1093/nar/24.2.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Escudé C., Giovannangeli C., Sun J. S., Lloyd D. H., Chen J. K., Gryaznov S. M., Garestier T., Hélène C. Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4365–4369. doi: 10.1073/pnas.93.9.4365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gagnor C., Rayner B., Leonetti J. P., Imbach J. L., Lebleu B. Alpha-DNA.IX: Parallel annealing of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription. Nucleic Acids Res. 1989 Jul 11;17(13):5107–5114. doi: 10.1093/nar/17.13.5107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Giovannangeli C., Diviacco S., Labrousse V., Gryaznov S., Charneau P., Helene C. Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):79–84. doi: 10.1073/pnas.94.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gryaznov S. M., Lloyd D. H., Chen J. K., Schultz R. G., DeDionisio L. A., Ratmeyer L., Wilson W. D. Oligonucleotide N3'-->P5' phosphoramidates. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5798–5802. doi: 10.1073/pnas.92.13.5798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gryaznov S. M., Lloyd D. H. Modulation of oligonucleotide duplex and triplex stability via hydrophobic interactions. Nucleic Acids Res. 1993 Dec 25;21(25):5909–5915. doi: 10.1093/nar/21.25.5909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gryaznov S., Skorski T., Cucco C., Nieborowska-Skorska M., Chiu C. Y., Lloyd D., Chen J. K., Koziolkiewicz M., Calabretta B. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. Nucleic Acids Res. 1996 Apr 15;24(8):1508–1514. doi: 10.1093/nar/24.8.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hélène C., Toulmé J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990 Jun 21;1049(2):99–125. doi: 10.1016/0167-4781(90)90031-v. [DOI] [PubMed] [Google Scholar]
  17. Kibler-Herzog L., Zon G., Uznanski B., Whittier G., Wilson W. D. Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers. Nucleic Acids Res. 1991 Jun 11;19(11):2979–2986. doi: 10.1093/nar/19.11.2979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lavignon M., Bertrand J. R., Rayner B., Imbach J. L., Malvy C., Paoletti C. Inhibition of Moloney murine leukemia virus reverse transcriptase by alpha-anomeric oligonucleotides. Biochem Biophys Res Commun. 1989 Jun 30;161(3):1184–1190. doi: 10.1016/0006-291x(89)91367-3. [DOI] [PubMed] [Google Scholar]
  19. Lavignon M., Tounekti N., Rayner B., Imbach J. L., Keith G., Paoletti J., Malvy C. Inhibition of murine leukemia viruses by nuclease-resistant alpha-oligonucleotides. Antisense Res Dev. 1992 Winter;2(4):315–324. doi: 10.1089/ard.1992.2.315. [DOI] [PubMed] [Google Scholar]
  20. Liquier J., Letellier R., Dagneaux C., Ouali M., Morvan F., Raynier B., Imbach J. L., Taillandier E. Triple helix formation by alpha-oligodeoxynucleotides: a vibrational spectroscopy and molecular modeling study. Biochemistry. 1993 Oct 12;32(40):10591–10598. doi: 10.1021/bi00091a008. [DOI] [PubMed] [Google Scholar]
  21. Milligan J. F., Matteucci M. D., Martin J. C. Current concepts in antisense drug design. J Med Chem. 1993 Jul 9;36(14):1923–1937. doi: 10.1021/jm00066a001. [DOI] [PubMed] [Google Scholar]
  22. Morvan F., Porumb H., Degols G., Lefebvre I., Pompon A., Sproat B. S., Rayner B., Malvy C., Lebleu B., Imbach J. L. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem. 1993 Jan 22;36(2):280–287. doi: 10.1021/jm00054a013. [DOI] [PubMed] [Google Scholar]
  23. Morvan F., Rayner B., Imbach J. L., Thenet S., Bertrand J. R., Paoletti J., Malvy C., Paoletti C. alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases. Nucleic Acids Res. 1987 Apr 24;15(8):3421–3437. doi: 10.1093/nar/15.8.3421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Riazance J. H., Baase W. A., Johnson W. C., Jr, Hall K., Cruz P., Tinoco I., Jr Evidence for Z-form RNA by vacuum UV circular dichroism. Nucleic Acids Res. 1985 Jul 11;13(13):4983–4989. doi: 10.1093/nar/13.13.4983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schultz R. G., Gryaznov S. M. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties. Nucleic Acids Res. 1996 Aug 1;24(15):2966–2973. doi: 10.1093/nar/24.15.2966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Skorski T., Perrotti D., Nieborowska-Skorska M., Gryaznov S., Calabretta B. Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3966–3971. doi: 10.1073/pnas.94.8.3966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thenet S., Morvan F., Bertrand J. R., Gautie C., Malvy C. Alpha are more stable than beta anomer oligonucleotides in 3T3 cellular extracts. Biochimie. 1988 Dec;70(12):1729–1732. doi: 10.1016/0300-9084(88)90031-4. [DOI] [PubMed] [Google Scholar]
  28. Tunis-Schneider M. J., Maestre M. F. Circular dichroism spectra of oriented and unoriented deoxyribonucleic acid films--a preliminary study. J Mol Biol. 1970 Sep 28;52(3):521–541. doi: 10.1016/0022-2836(70)90417-1. [DOI] [PubMed] [Google Scholar]
  29. Wilson W. D., Mizan S., Tanious F. A., Yao S., Zon G. The interaction of intercalators and groove-binding agents with DNA triple-helical structures: the influence of ligand structure, DNA backbone modifications and sequence. J Mol Recognit. 1994 Jun;7(2):89–98. doi: 10.1002/jmr.300070206. [DOI] [PubMed] [Google Scholar]
  30. Yamaguchi T., Saneyoshi M. Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2'-deoxy-alpha-D-ribofuranosyl nucleosides and nucleotides. Chem Pharm Bull (Tokyo) 1984 Apr;32(4):1441–1450. doi: 10.1248/cpb.32.1441. [DOI] [PubMed] [Google Scholar]
  31. Zamecnik P. C., Stephenson M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978 Jan;75(1):280–284. doi: 10.1073/pnas.75.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zhang R., Yan J., Shahinian H. K., Shahinian H., Amin G., Lu Z., Liu T., Saag M. S., Jiang Z., Temsamani J. Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther. 1995 Jul;58(1):44–53. doi: 10.1016/0009-9236(95)90071-3. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES